Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Trial Profile

ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Pulmonary sarcoidosis
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jan 2015 Planned End Date changed from 1 Dec 2016 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
    • 27 Jan 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
    • 16 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top